Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015;1(3):95-104.
doi: 10.17756/jrds.2015-016. Epub 2015 Oct 23.

Dopamine in the Brain: Hypothesizing Surfeit or Deficit Links to Reward and Addiction

Affiliations

Dopamine in the Brain: Hypothesizing Surfeit or Deficit Links to Reward and Addiction

Kenneth Blum et al. J Reward Defic Syndr. 2015.

Abstract

Recently there has been debate concerning the role of brain dopamine in reward and addiction. David Nutt and associates eloquently proposed that dopamine (DA) may be central to psycho stimulant dependence and some what important for alcohol, but not important for opiates, nicotine or even cannabis. Others have also argued that surfeit theories can explain for example cocaine seeking behavior as well as non-substance-related addictive behaviors. It seems prudent to distinguish between what constitutes "surfeit" compared to" deficit" in terms of short-term (acute) and long-term (chronic) brain reward circuitry responsivity. In an attempt to resolve controversy regarding the contributions of mesolimbic DA systems to reward, we review the three main competing explanatory categories: "liking", "learning", and "wanting". They are (a) the hedonic impact -liking reward, (b) the ability to predict rewarding effects-learning and (c) the incentive salience of reward-related stimuli -wanting. In terms of acute effects, most of the evidence seems to favor the "surfeit theory". Due to preferential dopamine release at mesolimbic-VTA-caudate-accumbens loci most drugs of abuse and Reward Deficiency Syndrome (RDS) behaviors have been linked to heightened feelings of well-being and hyperdopaminergic states.The "dopamine hypotheses" originally thought to be simple, is now believed to be quite complex and involves encoding the set point of hedonic tone, encoding attention, reward expectancy, and incentive motivation. Importantly, Willuhn et al. shows that in a self-administration paradigm, (chronic) excessive use of cocaine is caused by decreased phasic dopamine signaling in the striatum. In terms of chronic addictions, others have shown a blunted responsivity at brain reward sites with food, nicotine, and even gambling behavior. Finally, we are cognizant of the differences in dopaminergic function as addiction progresses and argue that relapse may be tied to dopamine deficiency. Vulnerability to addiction and relapse may be the result of the cumulative effects of dopaminergic and other neurotransmitter genetic variants and elevated stress levels. We therefore propose that dopamine homeostasis may be a preferred goal to combat relapse.

Keywords: Dopamine receptors; Incentive salience; Learning; Liking and wanting; Neurogenetics; Reward deficiency syndrome; Surfeit.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic view of dopaminergic genetics and post-junction receptor density (with permission-Postgrad Med 2009 Nov; 121(6): 176–196 doi: 10.3810/ pgm.2009.11.2087)

Similar articles

Cited by

References

    1. Nutt DJ, Lingford-Hughes A, Erritzoe D, Stokes PR. The dopamine theory of addiction: 40 years of highs and lows. Nat Rev Neurosci. 2015;16(5):305–312. doi: 10.1038/nrn3939. - PubMed
    1. Blum K, Sheridan PJ, Wood RC, Braverman ER, Chen TJ, et al. The D2 dopamine receptor gene as a determinant of reward deficiency syndrome. J Royal Soc Med. 1996;89(7):396–400. doi: 10.1177/014107689608900711. - PMC - PubMed
    1. Bowirrat A, Oscar-Berman M. Relationship between dopaminergic neurotransmission, alcoholism, and Reward Deficiency syndrome. Am J Med Genet B Neuropsychiatr Genet. 2005;132B(1):29–37. doi: 10.1002/ajmg.b.30080. - PubMed
    1. Koob GF, Buck CL, Cohen A, Edwards S, Park PE, et al. Addiction as a stress surfeit disorder. Neuropharmacology. 2014;76:370–382. Pt B. doi: 10.1016/j.neuropharm.2013.05.024. - PMC - PubMed
    1. Blum K, Febo M, Thanos PK, Baron D, Fratantonio J, et al. Clinically combating Reward Deficiency Syndrome (RDS) with dopamine agonist therapy as a paradigm shift: dopamine for dinner? Mol Neurobiol. 2015;52(3):1862–1869. doi: 10.1007/s12035-015-9110-9. - PMC - PubMed

LinkOut - more resources